Letters to the Editor

Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children

Center for Thrombosis and Hemostasis, Skåne University Hospital, Malmö, Sweden; Department of Pediatrics, Skåne University Hospital, Lund, Sweden; Department of Clinical Sciences and Pediatrics, Lund University, Lund
Department of Pediatrics, Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium
Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital, University Hospital, University of Bern, Bern
Royal Hospital for Children, Glasgow, UK
Department of Pediatric Oncology and Hematology, University Hospital, Aarhus, Denmark
Department of Pediatrics, Skåne University Hospital, Lund
PedNet group, Table S1, Supplement
Vol. 109 No. 4 (2024): April, 2024 https://doi.org/10.3324/haematol.2023.284095